Powered by

Dyadic International Announces Stephen Warner Resignation

Apr 06, 2017 - GlobeNewswire
Board and Executive Moves

JUPITER, Fla., April 06, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (OTCQX:DYAI) ("Dyadic"), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible commercial scales, announced today that Stephen Warner has resigned from the Board of Directors of Dyadic (the 'Board'), effective June 1, 2017. His service on the audit, compensation, and nomina...